Since 2012, Findorff has completed numerous multi-phased, fast-tracked additions and renovations of active lab spaces, including classified ISO 7, ISO 8, and BSL2 spaces with redundancy of facility infrastructure. For this global leader in Phase I-IV drug development of gene and cell therapies, and small molecule pharmaceuticals delivering life changing therapies with speed and efficiency in a GMP Lab environment. Their facilities support scientists in various studies of cell-based assays, extractable and leachables, mass spectrometry and structural elucidation, microbiology, pharmaceutical material characterization, and stability studies.